Turkey 2017 Clinical Practice Guidelines on recommendations for screning diagnosing and managing hepatitis C virus
Makaleler > Tam Makale · 2017
Yazarlar: Ramazan İDİLMAN, Nurcan BAYKAM, Sabahattin KAYMAKOĞLU, Fehmi Tabak, Halil I. Bahcecioglu, Ahmet BEKTAŞ, Cemal BULUT, Fulya GÜNŞAR, Dilara İNAN, Hayat K. Karaosmanoglu, Abdullah Zeki KARASU, Ferit KUŞCU, Birgul METE, Omer ÖZBAKIR, Osman C. Ozdogan, Mehmet PARLAK, Fatma SIRMATEL, Omer Topalak, Belkis ÜNSAL
TURKISH JOURNAL OF GASTROENTEROLOGY, SCI Expanded İndekslerine Giren Dergi, Uluslararası, 2017, cilt 28, ss 90-93
DOI: 10.5152/tjg.2017.21
Özet
The present guideline updates the Turkish recommendations for the screening, diagnosis and management of Hepatitis C virus (HCV) infection prepared by the Turkish Association for the Study of the Liver (TASL) and Viral Hepatitis Society (VHS). The aim of this guidance was to provide updates recommendations to physicians, who are interested in HCV care on the optimal screening, diagnosis and pre-treatment management for patients with HCV infection in Turkey. These recommendations, produced by panel experts, were aimed to addresses the management issues ranging from diagnosis and linkage to care, to the optimal treatment regimen in patients with HCV infection. Recommendations are based on evidence and opinions of more than 70% of the panelists. This guidance is supported by the memberships of two societies and not by pharmaceutical companies. This guidance will be updated frequently as new data become available.